6-Chloro-9-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-9H-Purine

96%

Reagent Code: #160395
fingerprint
CAS Number 39824-26-5

science Other reagents with same CAS 39824-26-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 326.74 g/mol
Formula C₁₃H₁₅ClN₄O₄
thermostat Physical Properties
Melting Point 156-159°C
Boiling Point 527.8°C
inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

Used as an intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of nucleoside analogs. It plays a role in modifying the structure of nucleosides to enhance their stability and selectivity against specific enzymes involved in viral replication or tumor growth. Commonly employed in research settings for designing prodrugs and exploring structure-activity relationships in purine-based pharmaceuticals.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿165.00
inventory 1g
10-20 days ฿750.00
inventory 5g
10-20 days ฿3,500.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
6-Chloro-9-[2,3-O-(1-methylethylidene)-beta-D-ribofuranosyl]-9H-Purine
No image available

Used as an intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of nucleoside analogs. It plays a role in modifying the structure of nucleosides to enhance their stability and selectivity against specific enzymes involved in viral replication or tumor growth. Commonly employed in research settings for designing prodrugs and exploring structure-activity relationships in purine-based pharmaceuticals.

Used as an intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of nucleoside analogs. It plays a role in modifying the structure of nucleosides to enhance their stability and selectivity against specific enzymes involved in viral replication or tumor growth. Commonly employed in research settings for designing prodrugs and exploring structure-activity relationships in purine-based pharmaceuticals.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...